To explore whether RSPH14 is involved in the lnc-ZEB2-19-induced inhibition of HCC progression and LR, we first performed functional assays to knock down RSPH14 after sh-3# was selected for its satisfactory inhibition efficiency (Supplementary Figure S3G, H). The gene discussed is ZEB2; the disease is hepatocellular carcinoma.